Brochure | May 13, 2024

VirusExpress® Platform For Lentivirus

Virus GettyImages-154955697

Discover an experienced partner with an unparalleled track record and solutions to de-risk the production of your cell or gene therapy. Trusted to advance lentiviral cell and gene therapies for three decades, MilliporeSigma has the expertise to support your therapeutic from preclinical development through commercialization. Continue reading to learn about the ultimate solution to bring your lentivirus-based cell or gene therapy to GMP in less than 12 months.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online